Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Efficacy of Varenicline in Methadone-Stabilized Cocaine Users

Not Applicable

Completed

Conditions: Cocaine Dependence
Nicotine Dependence

Interventions: Drug: Sugar pill or Placebo
Drug: Varenicline

First Posted Date: 2007-12-04

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 31

Registration Number: NCT00567320

Locations: 🇺🇸
Veterans Hopsital, West Haven, Connecticut, United States

Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Device: Magstim Rapid 2 system triggering Magstim Super Rapid system
Device: Magstim Rapid-2 system triggering Magstim Super Rapid system

First Posted Date: 2007-12-04

Last Posted Date: 2020-09-17

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT00567281

Locations: 🇺🇸
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, United States

Ceftriaxone in the Management of Bipolar Depression

Not Applicable

Terminated

Conditions: Bipolar Depression

Interventions: Drug: Saline solution
Drug: ceftriaxone

First Posted Date: 2007-12-03

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT00566111

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Levetiracetam in the Management of Bipolar Depression

Not Applicable

Completed

Conditions: Bipolar Depression

Interventions: Drug: Placebo
Drug: Levetiracetam

First Posted Date: 2007-12-03

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 35

Registration Number: NCT00566150

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence

Phase 3

Completed

Conditions: Alcohol Dependence
Depression

Interventions: Drug: Mecamylamine
Drug: Placebo

First Posted Date: 2007-11-26

Last Posted Date: 2016-04-18

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT00563797

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

Phase 4

Completed

Conditions: Opiate Dependence

First Posted Date: 2007-11-08

Last Posted Date: 2019-01-14

Lead Sponsor: Yale University

Target Recruit Count: 113

Registration Number: NCT00555425

Locations: 🇺🇸
The APT Foundation, Inc. -- Welch Building, New Haven, Connecticut, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence

Phase 2

Completed

Conditions: HIV Infections
Opiate Dependence

Interventions: Behavioral: Standard Sexual Risk Management
Behavioral: Enhanced Sexual Risk Management

First Posted Date: 2007-10-23

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 22

Registration Number: NCT00548275

Locations: 🇺🇸
Methadone Research Unit, The APT Foundation, Inc., New Haven, Connecticut, United States
🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

Phase 2

Terminated

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: placebo
Drug: N-Acetylcysteine

First Posted Date: 2007-10-04

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT00539513

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

Not Applicable

Completed

Conditions: Opiate Dependence

Interventions: Behavioral: abstinence-contingent buprenorphine (ACB)
Behavioral: behavioral drug and HIV risk reduction counseling (BDRC)

First Posted Date: 2007-10-04

Last Posted Date: 2021-06-18

Lead Sponsor: Yale University

Target Recruit Count: 234

Registration Number: NCT00539123

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇲🇾
Substance Abuse Research Center, Muar, Johor, Malaysia

N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD

Phase 2

Terminated

Conditions: Self-Injurious Behavior
Borderline Personality Disorder

Interventions: Drug: placebo
Drug: N-Acetylcysteine

First Posted Date: 2007-10-04

Last Posted Date: 2020-04-15

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT00539188

Locations: 🇺🇸
Yale OCD Research Clinic, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy